Log In
person
Organon & Co
OGN
summarize
3 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| Biosimilars |
Biosimilars; sold through distributor
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
0.59B | 9.65% |
| Established Brands |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
3.85B | 62.63% |
| Women's Health |
Birth Control Pharmaceuticals
These companies research, develop, and manufacture drugs used to prevent pregnancy.
|
1.7B | 27.71% |
| keyboard_arrow_down |
Biosimilars
Biosimilars; sold through distributor
|
0.59B | 9.65% |
| keyboard_arrow_right |
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
||
| keyboard_arrow_down |
Established Brands
Branded Pharmaceuticals
|
3.85B | 62.63% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
Women's Health
Birth Control Pharmaceuticals
|
1.7B | 27.71% |
| keyboard_arrow_right |
These companies research, develop, and manufacture drugs used to prevent pregnancy.
|
||